Glucotrack (GCTK) Form 3: Director Reports No Shares Owned

Glucotrack, Inc. (GCTK) Form 3 shows that Brendel Victoria Carr is listed as a director and filed an initial Section 16 disclosure for the 05/22/2025 event date.

Accepted by SEC EDGAR 10/07/2025 - 09:57 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Glucotrack, Inc. (GCTK) Form 3 shows that Brendel Victoria Carr is listed as a director and filed an initial Section 16 disclosure for the 05/22/2025 event date. The filing states no securities are beneficially owned by the reporting person and includes an exhibit appointing a power of attorney for signature. This indicates the director currently holds no equity position disclosed under Section 16.

Positive

• Director identified as Brendel Victoria Carr, fulfilling disclosure duty
• No securities beneficially owned reported as of 05/22/2025, removing short‑term insider trading signals

Negative

• Director holds no equity, which may limit alignment with shareholders

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Glucotrack (GCTK) Form 3 disclose about the reporting person?

The Form 3 lists Brendel Victoria Carr as a director and indicates no securities are beneficially owned as of the reported event date.

When is the event date reported on the Glucotrack Form 3 (GCTK)?

The event date reported on the Form 3 is 05/22/2025.

Does the Form 3 show any derivative or non‑derivative holdings for the reporting person?

No. The filing explicitly states no securities are beneficially owned and lists no derivative or non‑derivative holdings.

Was a power of attorney included with the Form 3 for Glucotrack (GCTK)?

Yes. The filing includes an exhibit list noting Exhibit 24 – Power of Attorney.

Is this Form 3 a joint filing or filed by one reporting person for GCTK?

The form is indicated as filed by one reporting person.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

CARR BRENDEL VICTORIA

(Last) (First) (Middle)

C/O GLUCOTRACK, INC.

301 RTE. 17 NORTH, SUITE 800

(Street)

RUTHERFORD NJ 07070

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
05/22/2025

3. Issuer Name and Ticker or Trading Symbol
Glucotrack, Inc. [ GCTK ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Nelson Mullins Riley & Scarborough LLP, Attorney-in-Fact	10/07/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.